Cowen and Company’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,668	Closed	-$2.46M	–	653
2023 Q4	$2.46M	Buy	+18,668	New	+$2.46M	0.16%	96
2021 Q2	–	Sell	-3,537	Closed	-$344K	–	460
2021 Q1	$344K	Buy	+3,537	New	+$344K	0.02%	196
2020 Q4	–	Hold	0	–	–	–	308